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Abstract 
Introduction: Crohn’s Disease is a chronic and idiopathic inflammatory process with 
transmural invasion that can affect the entire gastrointestinal tract. The etiopathogenesis 
of this pathology is not fully understood and studies have been carried out to understand 
the influence of different kind of factors on its development, including appendectomy. 
This monograph aims to address the possible existence of a link between appendectomy 
and Crohn’s Disease, and the possible causes and clinical consequences of this 
association. 
Methods: This monograph was based on the research of original scientific articles in 
MEDLINE database via PubMed, restricted to articles in Portuguese and English during 
the period between 1991 and 2017. 
Results: Appendectomy seems positively associated with the development of Crohn’s 
Disease, especially in the first years of surgery, regardless of whether or not there is 
inflammation of the appendix. In fact, the appendix plays important roles in 
gastrointestinal integrity, acting in the development of an adequate immune response, 
maintaining and regulating the intestinal flora.  
Conclusion: The appendix is important for intestinal homeostasis, preventing the 
development of certain pathologies. Its resection, regardless of whether or not there is 
an inflammation after surgery, increases the risk of Crohn’s Disease and worsens the 
prognosis of this pathology, so appendectomy should be avoided in the absence of 
appendicitis. 
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Resumo 
Introdução: A Doença de Crohn é um processo inflamatório crónico e idiopático com 
atingimento transmural que pode afetar todo o trato gastrointestinal. A etiopatogenia 
desta patologia não está completamente esclarecida pelo que se tem vindo a realizar 
estudos para perceber a influência de diferentes fatores no seu desenvolvimento, entre 
os quais a apendicectomia. Esta monografia visa abordar a existência de uma possível 
relação entre apendicectomia e Doença de Crohn e as possíveis causas e 
consequências clínicas desta associação. 
Métodos: Esta monografia foi elaborada com base em artigos científicos originais 
pesquisados na base de dados MEDLINE via PubMed, com restrição a artigos em 
português e inglês com limite temporal de 1991 a 2017. 
Resultados: A apendicectomia parece associar-se positivamente ao desenvolvimento 
da Doença de Crohn, principalmente nos primeiros anos após a cirurgia, 
independentemente de haver ou não inflamação do apêndice. De facto, o apêndice 
desempenha importantes funções na integridade gastrointestinal, com influência no 
desenvolvimento de uma resposta imunológica adequada e na manutenção e regulação 
da flora intestinal.  
Conclusão: O apêndice é importante na homeostasia intestinal, prevenido o 
desenvolvimento de determinadas patologias. A sua ressecção, independentemente do 
facto de haver ou não inflamação aquando da cirurgia, aumenta o risco de Doença de 
Crohn e piora o prognóstico desta patologia, pelo que a apendicectomia deve ser evitada 
na ausência da doença. 
 
Palavras-Chave  
Doença de Crohn; Apendicectomia; Apendicite; Apêndice 
 
 
 
 
 
 
Introduction 
Inflammatory Bowel Disease (IBD) includes Crohn’s Disease (CD) and Ulcerative Colitis 
(UC) that are characterized by their inflammatory component. These diseases are 
thought to arise preferentially in genetically susceptible individuals when subjected to 
interactions between environmental, genetic, microbiological, and immunological factors. 
These entities continue to be a challenge for practitioners, since its etiology remains 
unclear, making it difficult to get more targeted treatments or preventive methods. These 
diseases affect several hundred thousand people worldwide, particularly 1.5 million 
Americans and 2.2 million Europeans.1 
Some risk factors such as tobacco, infection, pharmacological agents, stress, pollution, 
and diet have been studied, contributing to a better understanding of the underlying 
causes of these pathologies.2 
Lately, researchers have been interested in the influence of appendectomy in the course 
of these diseases. In fact, several studies have demonstrated a protective effect of this 
procedure on the onset and clinical course of UC. In CD, the studies are contradictory: 
some investigators found a negative association, others did not show any relation, and 
still others found that appendectomy plays a deleterious role in the onset and clinical 
course of the disease. 
 
 
 
 
 
 
 
 
 
 
 
 
Material and methods 
This monograph was elaborated based on original scientific articles searched in the 
MEDLINE database via PubMed, with a restriction made to articles in Portuguese and 
English with a time limit of 1991–2017. 
The research was performed using different combinations of terms: CD; IBD; Appendix, 
Appendectomy; Appendicitis.  
We selected the references taking into account their correspondence with the objectives 
sought in this review, with priority being given to the most recent and complete review 
articles. In addition, other articles were identified by cross-references of articles obtained 
in the initial research; articles considered pertinent to the work were included. In total, 39 
publications were included in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
Relationship between appendectomy and UC 
The relationship between appendectomy and UC is relatively well understood; one of the 
most recent review studies concluded that despite the contradictory results sometimes 
observed in different case–control studies, most of them demonstrated a protective 
effect.3 However, the mechanism underlying this association is still awaiting an 
explanation.2 
Patients undergoing UC after an appendectomy have a less severe presentation of the 
disease, with lower colectomy rates compared to patients not undergoing an 
appendectomy.4 
It was also been demonstrated in a case–control study that this relationship only applies 
to cases in which appendectomy was performed because of an inflammatory cause, e.g., 
appendicitis or mesenteric lymphadenitis. The relationship does not happen in cases of 
appendectomy performed by nonspecific abdominal pain. This finding suggests that 
what will actually influence the course of UC is the inflammatory state that precedes the 
surgery – not the appendectomy itself; and that, basically, the inflammation was caused 
by pathogenic factors different from those that gave rise to UC. Apart from this, the 
relationship will only be valid for surgeries performed before the age of 20; this indicates 
that the pathogenesis of appendicitis may be based on different causes, depending on 
the age group; and that the causal factors of this pathology in younger individuals may 
in some way contribute to the protective effect demonstrated with respect to UC.5 
Appendicitis: differential diagnosis of ileal CD 
Appendicitis is defined as an inflammation of the appendix mucosa, which subsequently 
affects the remaining layers of the wall. Despite the diagnostic and therapeutic advances, 
this pathology continues to be a clinical emergency and is one of the most usual causes 
of acute abdominal pain and the most common cause of emergency surgery.6 
Notably, appendicitis has an inconsistent clinical presentation. The classic history of 
anorexia, periumbilical pain with irradiation to the right iliac fossa, followed by nausea 
and vomiting occurs in only 50% of cases. At diagnosis, the physician should include 
medical history, physical examination, and laboratory tests with inflammatory markers at 
increased levels; however, one does not count with a result that is specific for 
appendicitis. Thus, in case of diagnostic doubt the clinician should use imaging studies 
(such as ultrasonography and computed tomography [CT]) and diagnostic laparoscopy.7 
Thus, it is clear why the overall precision in the diagnosis of acute appendicitis is 
approximately 80%.In fact, often the differential diagnosis of appendicitis is challenging, 
because its clinical picture is common to many pathologies that occur with abdominal 
pain, for example, CD, mesenteric lymphadenitis, enterocolitis, endometriosis, 
diverticulitis, and ischemic colitis, among many others.8 
In 75% of cases, CD affects the terminal ileum. The characteristic presentation of this 
disease includes abdominal pain, non-bloody diarrhea, weight loss, fever, and 
sometimes obstructive symptoms, such as nausea and vomiting, occurring in the same 
age range as appendicitis, especially in its first peak. To diagnose the pathology, the 
physician must go beyond the clinical findings, using imaging and laboratory data, the 
results of which are not specific; its main importance lies in the evaluation of the patient’s 
inflammatory and nutritional status.  
Thus, considering the similarity of the clinical presentation of these two pathologies and 
the fact that they preferentially affect patients of the same age group (preferably affecting 
children and youngsters),9 one can explain the frequent diagnostic errors that occur 
between these two nosological entities. Consequently, physicians should be aware of 
this possibility, when faced with patients with this symptomatology, to avoid errors of 
diagnosis.10 
Despite the clinical similarities, the treatment of these pathologies is different. In 
appendicitis patients, the treatment is surgical7; on the other hand, in CD, the treatment 
is essentially clinical. Aside from this, studies show that patients with a history of 
appendicitis followed by a diagnosis of CD have a worse prognosis, with higher 
percentages of recession versus CD patients not undergoing an appendectomy.11 But in 
many cases the similarities in clinical presentation cause the physician to perform an 
appendectomy as the first surgical approach in CD patients.12 Thus, it is critical to 
establish the diagnosis of CD quickly so that the correct treatment is started as early as 
possible; this will contribute to an improvement in the quality of life of these patients.9 For 
this reason, some preoperative evidence has been studied to diagnose CD more 
effectively: a history of abdominal pain or recurrent diarrhea, laboratory results 
compatible with the existence of a chronic process (e.g., microcytic anemia, 
hypoproteinemia, hypoalbuminemia, hypocholesterolemia)13 and an increased platelet 
count.9 It is also valid that the clinician uses imaging methods (ultrasonography and CT) 
to assist in the differentiation between these pathologies.8 
Aside from the difficulty in differentiating the two pathologies, there are cases in which 
these entities are related in amore interconnected way, and there may even be a 
progression from granulomatous appendicitis to an aggressive CD.14 According to the 
most recent guidelines regarding the diagnosis and treatment of appendicitis, postponing 
surgery in 12/24 h in the case of uncomplicated appendicitis does not increase the 
percentage of complications,7 which gives the surgeon time for a more efficient 
diagnostic study with fewer errors. 
CD in the appendix 
Despite its proximity to the ileum, an inflammatory involvement of the appendix is 
uncommon15; However, this organ has been increasingly studied, in search of a better 
understanding of the pathogenesis of intestinal diseases.  
It is important to differentiate acute appendicitis from Versus CD with appendix 
involvement. The latter situation occurs more frequently in young patients, with a 
predominance of males.  
Compared with CD found in other parts of the gastrointestinal tract, CD in the appendix 
has a lower percentage of recurrence and apparently with a better prognosis; in these 
cases, the first-line treatment is an appendectomy.15 
Although the symptoms on CD with appendix involvement are very similar to the 
symptoms of appendicitis, they are more recurrent and with a longer course. 
Histologically, it is possible to easily differentiate these pathologies, since appendages 
with CD present specific characteristics such as transmural, focal or discontinuous 
inflammation, predominantly with histiocytic and lymphocytic features. It is possible to 
observe crypt distortion, granulomas and erosions or ulcers. In some cases, a fibrous 
obliteration of the appendix lumen is observed; this can be explained by the existence of 
a recurrent inflammation in the course of the disease, evolving to cicatrization. It has also 
been shown that patients with CD in the appendix exhibit a more diffuse involvement of 
the colon.12 
Finally, in certain cases, granulomatous appendicitis may actually be a case of CD. 
However, it was observed that granulomatous appendicitis is a distinct entity from CD 
and that only 5–10% of patients with granulomatous appendicitis develop into CD.16 
Appendectomy: risk factor for onset and aggravating factor in the clinical features 
of CD 
As already mentioned, the relationship between appendectomy and UC is already 
relatively clear, and most studies show a protective effect. However, with regard to CD, 
the information about this association is still not very consistent. Some studies have 
shown a positive association between appendectomy and CD development.11,17–22 Other 
studies failed to prove any association,23 and there are even studies that have shown a 
negative association,4 as in UC. The inconsistencies between studies may be explained 
by the heterogeneity of the protocols followed, or by the inherent differences between 
studies.24 A recent meta-analysis of several studies has shown that, despite 
heterogeneity, there is a higher relative risk of CD after an appendectomy.24 
Time elapsed between appendectomy and CD 
Some studies have stratified the risk of CD occurrence after an appendectomy, taking 
into account the time elapsed between surgery and the diagnosis of the disease.11,17–19 
In some of these studies, it was found that the risk of CD is significantly increased during 
the early stages after the appendectomy, but then this risk gradually decreases to a non-
significant level.17–19,22 Other studies state that the risk remains high even10 years after 
surgery.11 The aforementioned meta-analysis summarized that the time elapsed since 
appendectomy has implications for the development of CD and that the risk of CD 
occurrence after appendix removal is significantly increased in the first year after surgery 
(the risk increases sevenfold),remains increased 1–4 years after the intervention, and 
only after 5 years does the risk becomes statistically insignificant.24 
Confounders 
Although this possible association has been advocated in several studies, it must be 
borne in mind that, because CD is a multifactor entity, several factors may have made 
this conclusion fallacious, for example, the existence of confounders, among which 
tobacco stands out. In fact, a possible relationship between tobacco and appendicitis 
has been demonstrated.25 Considering that this risk factor is also implicated in CD,26 is, 
therefore, a confounding factor in these studies. In studies making adjustments for this 
factor, no statistically significant differences were found in their results.4, 20 
Diagnostic bias 
Some authors state that, in fact, the increased risk of CD after an appendectomy, 
especially considering that this risk is increased, most clearly in the early times after 
surgery, with a decreased risk over time,24 is due to a diagnosticbias.18,22 As already 
mentioned, CD can be clinically similar to appendicitis; and the possible involvement of 
the appendix in a CD patient is a possibility that also contributes to the existence of a 
diagnostic bias. In the above-mentioned meta-analysis, the risk becomes elevated only 
in the first 5 years after an appendectomy.24 But there is evidence that the risk remains 
increased if the follow-up is started 10 years after surgery – exceeding the prodromal 
period of appendicitis, thereby counteracting the hypothesis that this association is due 
only to a misdiagnosis of CD at the time of the appendicitis episode. 
The same study revealed that the risk of CD was increased in patients whose appendix 
showed no inflammation at the time of appendectomy.11 Although not presenting 
macroscopic inflammatory characteristics, inflammation can be evidenced in histological 
studies,7 and may even have concordant characteristics with CD in a preclinical state, 
corroborating the diagnostic bias hypothesis.11 
Diagnosis underlying acute appendicitis 
By showing that the risk of developing CD was increased after appendectomy due to 
perforating appendicitis, mesenteric lymphadenitis, and non-specific abdominal pain, 
different studies showed that this association does not depend on the inflammatory or 
non-inflammatory nature of the underlying cause of the surgery.11, 22 
Age 
An increased risk for CD occurs only when surgery is performed on adults; therefore, 
appendectomies performed in children are excluded, 11, 22 contrary to what occurs in UC 
(in which there is a decreased risk of CD if appendectomy is performed in childhood).5 
Location of CD 
Studies evaluating the effect of appendectomy on CD localization have shown a lower 
incidence of colic involvement 27 and a greater probability of ileal involvement,4, 22, 28, 29 
and that these cases mimic more closely appendicitis symptomatology.22 
Prognosis 
Regarding the effect of appendectomy performed prior to the diagnosis of CD, studies 
have demonstrated that this surgery is related to a worse prognosis of the disease, 
translated by the need of systemic steroids, immunosuppressive drugs, biological 
agents, and surgical treatment, namely, recession surgery.27 Other studies have 
revealed no association,4 and others still suggest that only a change in the course occurs, 
which translates into an increased probability of surgery in cases of perforated 
appendicitis.11 
It appears that an appendectomy performed prior to CD diagnosis decreases the 
development of extra intestinal manifestations, particularly in the joints.27 
Finally, there seems to be a relationship between previous appendectomy and a higher 
risk of stenosis and a lower risk of a fistulous disease and perineal involvement.29 
Etiopathogeny of CD 
Currently, the main factors involved in the etiopathogenesis of CD are environmental and 
genetic ones, associated with imbalances of the intestinal flora and with changes in the 
immune system promoting the genesis of a dysregulated immune response that is the 
basis of chronic intestinal inflammation.30 
Immune response modification 
Faced with an aggression, a vast group of cells (including macrophages, neutrophils, 
monocytes, and dendritic, mesenchymal, and epithelial cells) mediates an innate 
immune response. Initially, there is leukocyte infiltration of the mucosa – a finding 
observed throughout the course of the disease. In fact, these cells are responsible for 
oxidation processes, with consequent destruction and perforation of tissues, leading to 
the release of inflammatory mediators. The process is at the basis of the dysfunction of 
the epithelial barrier, characteristic of CD.30 
Likewise, adaptive immunity also appears to play an important role in the pathogenesis 
of CD. On the one hand, with regard to humoral immunity, in CD there occurs a 
generalized activation of the immune response, in which the production of the different 
subclasses of immunoglobulin shows alteration. It has been found that CD patients tend 
to develop antibodies against a number of antigens characteristic of certain bacteria such 
as Saccharomyces cerevisiae and Escherichia coli. Although there is no evidence of a 
direct association between the presence of these antibodies and the development of CD, 
it has been proven that higher levels of these antibodies are related to a worse prognosis 
and to a worsening of the clinical course. On the other hand, as regards to T cells, their 
ability to adapt to stimuli should be emphasized, which allows an adjustment of the 
response to the different characteristics of the organism (e.g., gender and age) and to 
the presence of microorganisms, thus ensuring immunological homeostasis. If this 
adaptive capacity is compromised, this will affect the reestablishment of this equilibrium 
after the occurrence of the damage, promoting the maintenance of immune response 
that is the basis of chronic inflammation. In fact, regulatory T cells (Treg) are critical in 
innate and adaptive immunity, being important both in the development of self and non-
self-tolerance. Consequently, defects in these cells may be on the basis of autoimmune 
and inflammatory diseases, such as CD. 
The function of Treg cells remains poorly defined; it is known only that the number and 
state of activation of these cells are sensitive to changes in the intestinal flora and in the 
inflammatory state of the disease. It was found that during the active phase, the amount 
of these cells increase in the lamina propria, with a concomitant decrease in peripheral 
blood.30 
It is noteworthy that inappropriate immune responses maybe based on a change in the 
balance between T-helper 1 (Th1) and T-helper 2 (Th2) lymphocytes, since CD is 
characterized by a Th1-cell-mediated response.13 It has been shown that pregnancy 
status has a protective effect on the development of appendicitis, particularly during the 
third trimester of gestation. In pregnancy, there is a decrease in the Th1-cell-mediated 
inflammatory response with a predominance of Th2 cell action and an increase in 
humoral inflammatory response in favor of a decrease in cellular inflammatory response. 
These and other physiological changes characteristic of pregnancy may interfere with 
the pathogenesis of appendicitis.31 Thus, because it is an inflammatory process and in 
view of the inverse relationship between this factor and pregnancy, it is possible to 
conclude that the inflammatory process of appendicitis may be mediated by a Th1-cell 
response. This may help explain the possible aggravating effect of appendicitis in 
CDpatients.13 
Other processes that may explain the importance of the appendix on the etiology of IBD 
have been described. Although apparently more related to UC, these pathways may in 
some way influence the pathogenesis of CD; but there is little information on this subject. 
Among these processes, we can highlight the production of immunoglobulin A (IgA), the 
significant presence of natural killer T-cells (NKT) in the appendix, and the action of Th17 
cells, influenced by appendectomy. 
The appendix is important in the production of IgA, which has a relevant role in the 
defense against pathogenic microorganisms. Thus, appendectomy will cause a 
decrease in this protective pathway, leading to pathological processes. In fact, 
experimental studies in animals reveal that performing an appendectomy at young ages 
may lead to decreased levels of immunoglobulin in the mucosa, interfering with humoral 
intestinal immunity.32 
As far as NKT cells are concerned, these lymphocytes are present in a greater amount 
in the appendix compared to the other parts of the intestine. However, the true 
mechanism of these cells in intestinal pathophysiology has not yet been fully 
elucidated.33 
Finally, a new pathway has been described that demonstrates the influence of a subtype 
of CD4+ cells (IL-17-secreting Th17 cells) on the inflammation characteristic of 
autoimmune and inflammatory diseases, such as CD. The action of these cells is 
recruited by the influence of CCL20 chemokine that binds to the CCR6 receptor; both 
are present at higher levels in the colon of patients with IBD. On the other hand, 
laboratory studies have revealed that, in relation to appendicitis and appendectomy, the 
genetic expression of CCL20 in the distal colon undergoes down-regulation, with 
subsequent suppression of this inflammatory pathway. Thus, these new findings may 
allow the development of techniques that allow the modeling of this inflammatory 
pathway, with repercussions in the discovery of new therapeutics for CD.6 
Genetic susceptibility 
Genetic susceptibility also influences the development of IBD; in total, 200 risk loci have 
been identified34 that harbor genes with effects on the modulation of cytokine production, 
on the function of T cells and other components, and on the pathways present in 
inflammation.30 Indeed, the intestinal flora can be influenced by the host genotype. 
Variants of NOD2 and ATG16L genes appear to impair the normal barrier function of the 
intestinal mucosa in protecting against bacteria, which causes a change in the intestinal 
microbioma – a thing which will have repercussions on the development of the immune 
system and, consequently, on the onset of CD, as will be discussed later.35 
Intestinal microbioma interference 
The gastrointestinal tract is the site of the human body where the largest amount of 
microorganisms is found,30 representing a diverse set of agents that are related in a 
defined phylogenetic ratio and whose preservation allows the maintenance of 
homeostasis in the host.36 On the one hand, the genotype of the microorganisms 
interferes with the genetic expression of the host; but on the other hand, the presence of 
these microorganisms in the gastrointestinal tract is essential for the development and 
subsequent maturation of the immune system by allowing the establishment of a 
symbiotic relationship that will develop tolerance and protection.30 
Some factors, such as certain foods and food additives, tobacco, repeated exposure to 
antibacterial drugs, and acute events of gastroenteritis, cause changes in the 
composition and function of the intestinal flora. This modeling is most evident at younger 
ages.37 
This change could be responsible for an imbalance that possibly will lead to a higher CD 
risk. In fact, epidemiological evidence has shown that the higher incidence of diseases 
due to chronic inflammation and autoimmune pathologies is related to lower percentages 
of infectious pathologies and to the use of antibiotics and vaccinations. This evidence 
speaks in favor of the hypothesis that intestinal microorganisms play a fundamental role 
in the development of the immune system in the first years of life.30 
Bacterial translocation and microbial products from the intestinal lumen that cross the 
mucosa to the mesenteric lymph nodes allow for antigenic presentation. This contributes 
to the development of tolerance relative to endogenous microorganisms during 
childhood and its maintenance during adulthood, as well as to the development of gut-
associated lymphoid tissue (GALT).38 These bacterial antigens are necessary for the 
diversification of the repertoire of antibodies and also in the structuring of T- and B-cell 
areas in follicular centers, which have developed previously and independently of the 
antigenic presentation.34 
Lastly, it was found that intestinal bacteria are arrange din colonies that develop in a 
mucous matrix adherent to the luminal membrane of epithelial cells of intestinal microvilli, 
forming biofilms. Thus, there is the generation of a symbiotic association in which the 
host confers advantages (mainly metabolic ones) to the bacteria, contributing to a longer 
survival of the microorganisms.39 Likewise, commensal microbial agents protect the host 
by creating a physical barrier that hinders the entry of pathogens. In these biofilms, one 
can observe bacterial expulsion processes that allow the elimination of pathogenic 
microorganisms and the subsequent bacterial recolonization by commensal agents, with 
consequent biofilm regeneration.34 
The influence of the appendix on intestinal pathophysiology 
The appendix is a structure present in only a few mammals; in man, presents a peculiar 
architecture. Until recently, the function of this organ was not valued; it was thought that 
the appendix was nothing more than a vestigial and rudimentary remnant.39 However, 
with the publication of some studies proposing that appendectomy was associated with 
the development and evolution of IBD, the appendix acquired some prominence, 
becoming the target of several studies. 
First, the appendix has a specialized epithelium and houses cellular elements, such as 
B- and T-lymphocytes and dendritic cells, which allow the processing and presentation 
of antigens, with the subsequent genesis of an immune response.32 
In relation to the conservation of the intestinal flora, the appendix plays a prominent role. 
In fact, thanks to its particular structural characteristics (such as a narrow lumen) and 
because of its location, this organ is relatively protected from the pathogens present in 
the fecal material, which cannot reach or disturb its integrity. Thus, in cases of diarrhea 
– and unlike the case in the large intestine – there are no very pronounced changes in 
the appendicular flora and epithelium. Therefore, a post-diarrhea recolonization capacity 
appears to be exclusive to the appendix. Finally, the bacterial density and biofilm 
continuity along the epithelium are comparatively superior in the appendix, progressively 
decreasing to the distal end of the large intestine. All these characteristics let us realize 
that this organ is a safe place, which allows the preservation of commensal bacteria and, 
in addition, provides support for their growth. Moreover, in pathological situations that 
occur with the elimination of the constituents of the gastrointestinal tract, this organ 
allows the reintroduction of bacteria in the colon, contributing to the maintenance of an 
intestinal flora that, as we have seen, is essential for the maintenance of an intestine 
without pathology.34, 39 
Thus, one can note the importance of the appendix in maintaining balance and avoiding 
gastrointestinal pathology. Changes in the function of the appendix can trigger changes 
in the intestinal flora, which may be the basis of certain pathologies. If, as already 
discussed, the appendix plays a preponderant role in the immunological integrity and 
maintenance of the intestinal flora (and consequently in the integrity of the mucosa), its 
removal will impair the intestinal dynamics, being in the base of pathologies like CD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
It seems that appendectomy is positively associated with CD, increasing the risk of its 
occurrence and worsening prognosis. This association was advocated in several studies; 
however, it should be borne in mind that such an assumption may be due to diagnostic 
errors explained by the clinical similarities between CD and appendicitis, and by the 
possible involvement of the appendix in CD patients. 
According to the latest guidelines for the treatment of acute appendicitis, it is advisable 
to recess the appendix independently of its macroscopic characteristics, since in some 
cases it is possible to verify the presence of inflammation by histological analysis, even 
when no characteristic inflammatory conditions were observed during surgery.7 
However, considering that the possible association between appendectomy and CD 
does not seem to depend on the inflammatory nature of the pathology underlying the 
surgery, in clinical practice(especially in situations with possible presence of CD), the 
preservation of the appendix may be advantageous. The recession should be reserved 
for cases in which the physician is faced with a proven pathology, the treatment of which 
is necessarily surgical. In fact, the appendix has proved to be an essential component of 
intestinal homeostasis; thus, somehow the involvement or absence of this organ may 
contribute to the development of an intestinal pathology. 
Thus, studies allowing a better understanding of the association of appendectomy with 
the clinical course of CD are justifiable. These studies may help to better understand the 
etiology and pathogenesis of this disease; this knowledge can be applied in the 
prevention, diagnosis, and treatment of CD, which, due to its characteristics, results in 
great deterioration of patients’ quality of life. 
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Checklist (www.jcol.org.br)
For improved process and enhanced publication quality, we offer a checklist for your self-evaluation.
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been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to
Biomedical journals. Authors should include a statement in the manuscript that informed consent
was obtained for experimentation with human subjects. The privacy rights of human subjects must
always be observed.
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'Conflicts of interest: none'. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis or as an electronic
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Authorship criteria
All authors should have made substantial contributions to all of the following:
(1) the conception and design of the study, or acquisition of data, or analysis and interpretation of
data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval
of the version to be submitted.
Data collection and indexing are not authorship criteria. Likewise, authors are not technical assistants
that perform routine tasks, physicians that refer patients or interpret routine exams and heads of
services or departments not directly involved in the study. Special acknowledgments can be made
to these people.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their
manuscript and provide the definitive list of authors at the time of the original submission. Any
addition, deletion or rearrangement of author names in the authorship list should be made only
before the manuscript has been accepted and only if approved by the journal Editor. To request such
a change, the Editor must receive the following from the corresponding author: (a) the reason
for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of
authors after the manuscript has been accepted. While the Editor considers the request, publication
of the manuscript will be suspended. If the manuscript has already been published in an online issue,
any requests approved by the Editor will result in a corrigendum.
Records of clinical essays
The Journal of Coloproctology supports the guideline for clinical essay recording issued by the
World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE).
Articles on clinical essays will be accepted for publication only if an identification (ID) number has
been assigned by one of the Clinical Essay Record validated according to the criteria established
by the WHO and ICMJE, whose addresses are at (http://www.icmje.org). The ID number should be
displayed at the end of the abstract.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' to
assign to the society the copyright in the manuscript and any tables, illustrations or other material
submitted for publication as part of the manuscript (the "Article") in all forms and media (whether
now known or later developed), throughout the world, in all languages, for the full term of copyright,
effective when the Article is accepted for publication.
Author rights
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As an author you (or your employer or institution) have certain rights to reuse your work. For more
information on author rights please see http://www.elsevier.com/copyright.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective
work (such as an anthology), as long as they credit the author(s) and provided they do not alter or
modify the article.
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Submit your article
Please submit your article via http://www.evise.com/evise/jrnl/JCOL.
PREPARATION
Peer review
This journal operates a single blind review process. All contributions are typically sent to a minimum of
two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible
for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More
information on types of peer review.
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting
codes will be removed and replaced on processing the article. In particular, do not use the word
processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts (see
also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics
will be required whether or not you embed your figures in the text. See also the section on Electronic
artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article structure
The identification page
It should contain:
a) The article title, in Portuguese and English, which should be concise and informative; it should
express the manuscript content with precision. In addition, the title is important for physicians and
investigators to find an article in the bibliographical databases after it is published. Please, be sure
the title:
- Is not a question.
- Does not have colon or any punctuation that separates it in two parts.
- Does not reaffirm the article type. Ex.: Case Report, Review.
- Does not indicate the type of statistical analysis. Ex.: Multivariate Analysis.
- Does not include the institution name.
Full name of each author and institutional affiliation. Author affiliations should be presented in
decreasing hierarchical order (e.g. Harvard University, Harvard Business School, Boston, USA)
and should be written as established in its own language (e.g. Universit Paris-Sorbonne; Harvard
University, Universidade de So Paulo).
Name of the department and institution to which the paper should be attributed.
Name, address, e-mail of the corresponding author in charge.
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Sources of support to study development.
For studies presented in scientific meetings, indicate the meeting name, place, date, type of
presentation.
Abstract
The second page should have the abstract, in Portuguese and English, with no more than 250 words.
For original and review articles, the abstract structure should highlight the study objectives, methods,
main results with significant data and conclusions. For clinical information special articles, the abstract
does not need to be structured as mentioned above, but it should contain important information for
the study value recognition, as described in details in the publications: Haynes RB, Mulrow CD, Huth
EJ, Altman DG, Gardiner MJ. More informative abstracts revisited. Ann Intern Med 1990;113:69-76
Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative
abstracts of clinical articles. Ann Intern Med 1987;106:598-604.
Keywords
After the abstract, specify three to six terms in Portuguese and in English the subject of the study
should be included as well as the corresponding. Keywords in must be based on the Health and Science
Keywords (DeCS), published by Bireme and available at (http://decs.bvs.br), and Medical Subject
Headings (MeSH) is the Nation Library Medicine controlled vocabulary thesaurus used for indexing
articles for PubMed at (http://www.nlm.nih.gov/mesh/meshhome.html).
Abbreviations should be indicated when they first appear in the text. After that, the full name should
not be repeated.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Statistical analysis
The authors should demonstrate that the statistical procedures used in the study were not only
appropriate to test the study hypotheses, but also correctly interpreted. The levels of statistical
significance (ex. p < 0.05; p < 0.01; p < 0.001) should be mentioned.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or
use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is
finalized, please 'Save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of
500 dpi.
Please do not:
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• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a
low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Figures
The illustrations (pictures, charts, drawings,etc.) should be submitted individually. They should be
consecutively numbered, with Arabic numerals, in the order of their appearance in the text, and they
should be clear enough to enable their reproduction. Photocopies will not be accepted.
Tables
Please submit tables as editable text and not as images. Tables can be placed either next to the
relevant text in the article, or on separate page(s) at the end. Number tables consecutively in
accordance with their appearance in the text and place any table notes below the table body. Be
sparing in the use of tables and ensure that the data presented in them do not duplicate results
described elsewhere in the article. Please avoid using vertical rules and shading in table cells.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Data references
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them
in your text and including a data reference in your Reference List. Data references should include the
following elements: author name(s), dataset title, data repository, version (where available), year,
and global persistent identifier. Add [dataset] immediately before the reference so we can properly
identify it as a data reference. The [dataset] identifier will not appear in your published article.
Reference style
They should be consecutively numbered in the order of their appearance in the text and identified
with Arabic numerals. They should be presented according to the style presented by the List
of Journal Indexed Medicus, of the National Library of Medicine, which can be accessed at
http://www.nlm.gov/tsd/ serials/lji.html. The authors should be sure that in-text citations of
references are included in the list of references with exact dates and correctly spelled names of
authors. The accuracy of references is the authors` responsibility. Personal notes, unprecedented
studies or studies in progress may be cited when really required, but should not be included in the
list of references; only cited in the text or footnotes. Cite up to six authors for each reference. If any
reference has more than six authors, cite the six first names, followed by “et al.”. We request texts
with lean writing style. Shorter texts involve shorter revision and formatting times, and have higher
chances of quick publication.
RESEARCH DATA
This journal encourages and enables you to share data that supports your research publication
where appropriate, and enables you to interlink the data with your published articles. Research data
refers to the results of observations or experimentation that validate research findings. To facilitate
reproducibility and data reuse, this journal also encourages you to share your software, code, models,
algorithms, protocols, methods and other useful materials related to the project.
Below are a number of ways in which you can associate data with your article or make a statement
about the availability of your data when submitting your manuscript. If you are sharing data in one of
these ways, you are encouraged to cite the data in your manuscript and reference list. Please refer to
the "References" section for more information about data citation. For more information on depositing,
sharing and using research data and other relevant research materials, visit the research data page.
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